Browse > Article
http://dx.doi.org/10.15324/kjcls.2018.50.1.71

Laboratory Biosafety Status of Researchers in Korea  

Kim, Dae Sik (Department of Clinical Laboratory Science, Dongnam Health University)
Kim, Mi Kyung (Department of Systems Biology, Yonsei University)
Publication Information
Korean Journal of Clinical Laboratory Science / v.50, no.1, 2018 , pp. 71-76 More about this Journal
Abstract
This study examined the status of the laboratory biosafety of researchers in Korea during 03 Jan 2017~25 Mar 2017. Questionnaires were given out to 500 researchers working with pathogens in the laboratory of universities and institutes. According to the results, the respondents showed a high level of awareness but not compliance on the overall biosafety rules and regulations. Regarding the Biosafety facility level, 279 (55.8%) of respondents answered "know" and 221 (44.2%) of respondents answered "no". Despite the insufficient safety equipment and biosafety plans, researchers believed that appropriate safety measures could protect the workers and that their laboratories are safe. In a study involving biosafety education, 80% of the researchers had been trained in laboratory safety and 20% had never received safety education. The need for biosafety education was 66% and the satisfaction rate of education was 46%. These results suggest that the researchers already had experience in biosafety training, but they believed that continuing education is necessary. In addition, there were opinions that the most important thing to improve the biosafety status is to strengthen the training program and education system. In conclusion, it is necessary to develop a better training system for laboratory biosafety regarding the exposure risks.
Keywords
Biosafety; Injuries; Laboratory; Laboratory infection;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Gatherer D. The 2009 H1N1 influenza outbreak in its historical context. J Clin Virol. 2009;45(3):174-178.   DOI
2 Tellier R. Aerosol transmission of influenza A virus: a review of new studies. J R Soc Interface. 2009;6(Suppl 6):783-790.
3 WHO. Summary of human infection with highly pathogenic avian influenza A (H5N1) virus reported to WHO, January 2003- March 2009: cluster-associated cases. Wkly Epidemiol Rec. 2010;85:13-20.
4 Shaw K. The 2003 SARS outbreak and its impact on infection control practices. Public Health. 2006;120(1):8-14.   DOI
5 Zhao Z, Zhang F, Xu M, Huang K, Zhong W, Cai W, et al. Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. J Med Microbiol. 2003;52(Pt 8):715-720.   DOI
6 Nadjm B, Behrens RH. Malaria: an update for physicians. Infect Dis Clin North Am. 2012;26(2):243-259.   DOI
7 Lee C, Jung E, Kwon D, Choi H, Park JW, Bae GR. Laboratoryacquired dengue virus infection by needle stick injury. Ann Occp Environ Med. 2016;4:19-26.
8 Oliphant JW, Parker RR. Q fever: three cases of laboratory infection. Public Health Rep. 1948;63:1364-1370.
9 Beeman EA. Q fever: an epidemiological note. Public Health Rep. 1950;65:88-92.   DOI
10 Holmes GP, Hilliard JK, Klontz KC, Rupert AH, Schindler CM, Parrish E, et al. B virus (Herpesvirus simiae) infection in humans: epidemiologic investigation of a cluster. Ann Intern Med. 1990;112(11):833-839.   DOI
11 Barton Behravesh C, Mody RK, Jungk J, Gaul L, Redd JT, Chen S, et al. 2008 outbreak of Salmonella Saintpaul infections associated with raw produce. N Engl J Med. 2011;364:918-927.   DOI
12 Cho A, Seok SH. Ethical guidelines for use of experimental animals in biomedical research. J Bacteriol Virol. 2013;43(1):18-26.   DOI
13 CDC. Guidelines for biosafety in microbiological and biomedical laboratories [Internet]. Atlanta: CDC; 2018 [cited 2018 Jan 30]. Available from: https://www.cdc.gov/biosafety/publications/bmbl5/.
14 KCDC. Guideline for laboratory biosafety [Internet]. Cheongju: KCDC; 2018 [cited 2018 Jan 30]. Available from: http://cdc.go.kr/CDC/cms/content/mobile/68/69068_view.html.
15 Lee KM, Nam HY, Shin SH, Choi MK, Choi YJ, Kwon SH, et al. A survey on laboratory biosafety status of public healthcare centers in Korea. J Bacteriol Virol. 2013;43(3):217-228.   DOI
16 Barkham TM. Laboratory safety aspects of SARS at biosafety level 2. Ann Acad Med Singapore. 2004;33(2):252-256.
17 Lee JY, Eun SJ, Park KD, Kim JK, Im JS, Hwang YS. Biosafety of microbiological laboratories in Korea. J Prev Med Public Health. 2005;38(4):449-456.
18 Yoo KN, Park JI, Park TJ, Choi MK, Lee CH. Laboratory safety management system and its role on the performance of safety-related activities in Korean academia. Kor J Env Hlth. 2005;31(5):365-371.
19 Support Center for Laboratory Safety. Laboratory safety for researchers [Internet]. Daejeon: National Research Foundation of Korea; 2012 [cited 2018 Jan 30]. Available from: http://www.semsafety.or.kr/Upload/Board/File/201207/20120409_LaboratorySafety.pdf.
20 Kisskalt K. Laboratory infections with typhoid bacilli. Journal of Hygiene and Infectious Diseases. 1915;80:145-162.
21 Advisory Committee on Dangerous Pathogens. The approved list of biological agents [Internet]. London: Health and Safety Executive; 2018 [cited 2018 Jan 30]. Available from: http://www.hse.gov.uk/pubns/misc208.pdf.
22 Office of Laboratory Security. The laboratory biosafety guidelines. 3th. 2004 [Internet]. Ottawa: Minister of Health; 2018 [cited 2018 Jan 30]. Available from: http://www.phac-aspc.gc.ca/publicat/lbg-ldmbl-04/pdf/lbg_2004_e.pdf.